These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7680092)
21. 4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors. Micheletti R; Giudici L; Turconi M; Donetti A Br J Pharmacol; 1990 Jul; 100(3):395-7. PubMed ID: 1697193 [TBL] [Abstract][Full Text] [Related]
22. Discovery & development of selective M3 antagonists for clinical use. Alabaster VA Life Sci; 1997; 60(13-14):1053-60. PubMed ID: 9121347 [TBL] [Abstract][Full Text] [Related]
23. Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes. Waelbroeck M; Camus J; Tastenoy M; Feifel R; Mutschler E; Tacke R; Strohmann C; Rafeiner K; Rodrigues de Miranda JF; Lambrecht G Br J Pharmacol; 1994 Jun; 112(2):505-14. PubMed ID: 8075869 [TBL] [Abstract][Full Text] [Related]
24. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens. Eltze M Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712 [TBL] [Abstract][Full Text] [Related]
25. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens. Eltze M Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317 [TBL] [Abstract][Full Text] [Related]
26. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233 [TBL] [Abstract][Full Text] [Related]
27. Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation. Velazquez-Moctezuma J; Gillin JC; Shiromani PJ Brain Res; 1989 Nov; 503(1):128-31. PubMed ID: 2482113 [TBL] [Abstract][Full Text] [Related]
28. Contraction of guinea-pig gallbladder: muscarinic M3 or M4 receptors? Eltze M; König H; Ullrich B; Grebe T Eur J Pharmacol; 1997 Jul; 332(1):77-87. PubMed ID: 9298928 [TBL] [Abstract][Full Text] [Related]
29. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion. Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648 [TBL] [Abstract][Full Text] [Related]
30. [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]-trimethylammonium (McN-A-343)-related compounds. Effect of the butynyl chain inclusion into an aromatic unit on the potency for muscarinic receptors. Tumiatti V; Angeli P; Andrisano V; Bolognesi ML; Cavalli A; Marucci G; Minarini A; Recanatini M; Rosini M; Melchiorre C Bioorg Med Chem; 2000 Apr; 8(4):681-9. PubMed ID: 10819156 [TBL] [Abstract][Full Text] [Related]
31. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type. Eltz M; Gmelin G; Wess J; Strohmann C; Tacke R; Mutschler E; Lambrecht G Eur J Pharmacol; 1988 Dec; 158(3):233-42. PubMed ID: 2472963 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the interaction of zamifenacin at muscarinic receptors in vitro. Watson N; Reddy H; Stefanich E; Eglen RM Eur J Pharmacol; 1995 Oct; 285(2):135-42. PubMed ID: 8566131 [TBL] [Abstract][Full Text] [Related]
33. Affinity profiles of pizotifen, ketotifen and other tricyclic antimuscarinics at muscarinic receptor subtypes M1, M2 and M3. Eltze M; Mutschler E; Lambrecht G Eur J Pharmacol; 1992 Feb; 211(3):283-93. PubMed ID: 1377628 [TBL] [Abstract][Full Text] [Related]
35. Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation. Bradley KN; Rowan EG; Harvey AL Toxicon; 2001 Apr; 39(4):581-7. PubMed ID: 11024498 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach. Kromer W; Baron E; Beinborn M; Boer R; Eltze M Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):165-70. PubMed ID: 1692974 [TBL] [Abstract][Full Text] [Related]
37. Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors. Angeli P; Marucci G; Buccioni M; Piergentili A; Giannella M; Quaglia W; Pigini M; Cantalamessa F; Nasuti C; Novi F; Maggio R; Qasem AR; Spampinato S Life Sci; 2002 Feb; 70(12):1427-46. PubMed ID: 11883718 [TBL] [Abstract][Full Text] [Related]
38. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343 [TBL] [Abstract][Full Text] [Related]
39. Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney. Eltze M; Ullrich B; Mutschler E; Moser U; Bungardt E; Friebe T; Gubitz C; Tacke R; Lambrecht G Eur J Pharmacol; 1993 Jul; 238(2-3):343-55. PubMed ID: 8405103 [TBL] [Abstract][Full Text] [Related]
40. Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes. Eltze M; Figala V Eur J Pharmacol; 1988 Dec; 158(1-2):11-9. PubMed ID: 3220113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]